Starting from this observation, we hypothesized that modulation of the β3-AR signaling on tumor-infiltrating T cells, in particular on CD4+ and CD8+, could be responsible of an altered IFN-γ secretion, which in turn affected the PD-L1 expression on tumor cells. The gene discussed is ADRB3; the disease is neoplasm.